We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

480 hedge funds and large institutions have $6.97B invested in Jazz Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 183 increasing their positions, 160 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

14% more repeat investments, than reductions

Existing positions increased: 183 | Existing positions reduced: 160

0.86% more ownership

Funds ownership: 92% → 92.86% (+0.86%)

2% less capital invested

Capital invested by funds: $7.12B → $6.97B (-$152M)

4% less funds holding

Funds holding: 499 → 480 (-19)

18% less call options, than puts

Call options by funds: $19.5M | Put options by funds: $23.9M

21% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 68

Holders
480
Holders Change
-19
Holders Change %
-3.81%
% of All Funds
6.91%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.1%
New
54
Increased
183
Reduced
160
Closed
68
Calls
$19.5M
Puts
$23.9M
Net Calls
-$4.39M
Net Calls Change
-$11.9M

Top Buyers

1
Capital World Investors
Capital World Investors
California
+$175M
2
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$133M
3
CCM
Camber Capital Management
Massachusetts
+$58.2M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$53.9M
5
VPC
Vestal Point Capital
New York
+$45.9M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$128M
2
Swedbank
Swedbank
Sweden
-$127M
3
AC
Armistice Capital
New York
-$80.1M
4
Morgan Stanley
Morgan Stanley
New York
-$73.3M
5
Millennium Management
Millennium Management
New York
-$69.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Pictet Asset Management
26
Pictet Asset Management
Switzerland
$66M -$3.73M -30,442 -5%
Northern Trust
27
Northern Trust
Illinois
$65.7M -$7.79M -63,634 -10%
BNP Paribas Asset Management
28
BNP Paribas Asset Management
France
$57.5M -$28.8M -235,247 -33%
PL
29
Perpetual Ltd
Australia
$57.2M +$20.4M +166,543 +54%
Charles Schwab
30
Charles Schwab
California
$55.4M -$5.6M -45,710 -9%
N
31
Nuveen
North Carolina
$53.4M +$20.7M +168,618 +61%
BGIM
32
Brandywine Global Investment Management
Pennsylvania
$52.6M +$6.44M +52,537 +14%
Invesco
33
Invesco
Georgia
$46M -$270K -2,208 -0.6%
GKIM
34
GW&K Investment Management
Massachusetts
$43.8M -$382K -3,119 -0.9%
Legal & General Group
35
Legal & General Group
United Kingdom
$43.6M -$3.83M -31,295 -8%
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$42.5M +$9M +73,516 +26%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$37.3M +$3.9M +31,831 +11%
Robeco Institutional Asset Management
38
Robeco Institutional Asset Management
Netherlands
$36.6M -$922K -7,524 -2%
KBC Group
39
KBC Group
Belgium
$35.9M +$16.4M +134,198 +82%
Marshall Wace
40
Marshall Wace
United Kingdom
$32.3M +$29.3M +238,889 +817%
Russell Investments Group
41
Russell Investments Group
United Kingdom
$31.8M +$2.62M +21,368 +9%
TAM
42
Todd Asset Management
Kentucky
$29.3M +$8.98M +73,347 +43%
UBS AM
43
UBS AM
Illinois
$29.1M +$1.08M +8,805 +4%
SFM
44
Systematic Financial Management
New Jersey
$29M +$5.2M +42,451 +21%
Principal Financial Group
45
Principal Financial Group
Iowa
$28.6M +$621K +5,066 +2%
Wellington Management Group
46
Wellington Management Group
Massachusetts
$28.2M -$128M -1,046,379 -82%
Wells Fargo
47
Wells Fargo
California
$26.8M +$13.6M +111,301 +100%
ECM
48
Estuary Capital Management
Minnesota
$25.7M +$10.5M +85,779 +67%
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$25M -$5.66M -46,194 -18%
Los Angeles Capital Management
50
Los Angeles Capital Management
California
$24.2M -$13.2M -108,118 -35%
1
2
3 4 5

JAZZ Hedge Fund Activity: Q1 2024 in Review

480 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q1 2024, worth a combined $6.97B — down 2.1% from $7.12B a quarter earlier.

Sellers outnumbered buyers: 68 funds closed out of JAZZ and 54 opened new positions — a net loss of 14 holders — while 160 trimmed existing stakes and 183 added.

The largest buyer was Capital World Investors, opening a new position worth an estimated $175M. The largest seller was Wellington Management Group, cutting an estimated $128M.

  • 480 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q1 2024, down from 499 in Q4 2023.
  • Funds reported $6.97B of Jazz Pharmaceuticals stock for Q1 2024, down 2.1% quarter-over-quarter.
  • 54 funds opened new Jazz Pharmaceuticals positions in Q1 2024 and 68 closed out, a net change of -14 holders.
  • The largest Jazz Pharmaceuticals buyer in Q1 2024 was Capital World Investors, an estimated $175M added.
  • The largest Jazz Pharmaceuticals seller in Q1 2024 was Wellington Management Group, an estimated $128M sold.

Based on aggregated 13F filings for Q1 2024.